HERBALIFE LTD. · Drugs, Proprietaries & Druggists' Sundries

HLF

Low riskNext report: In 7 days (est.)

View price ↗

The short version

A profitable company with steady sales.

Going well

Profitable every year for 10 years
Brings in more cash than it spends

Money moves

No insider buying or selling in the last 30 days
Institutions added 0.9% to their holdings in the quarter ending June 2026 (127 bought, 115 sold)
Held by Ray Dalio (Bridgewater), Seth Klarman (Baupost)

Facts from SEC filings, not a recommendation.

What the price means

Price as of Oct 26

$13.30-0.8% that day

Company value: $1.4B; Share price times all shares
Price vs profit (P/E): 8.5x; You pay about $9 for each $1 of yearly profit
Price vs sales: 0.27x; Company value is 0.27 times a year of sales
Cash vs value: 27%; Cash as a share of company value
Debt vs value: 143%; Owes more than the whole company is worth

From HLF's last IEX trade and its SEC filings (profits and sales over the last four quarters). A starting point for research, not a verdict.

The business over time

Last 12 quarters, from SEC filings

Sales, Jun '26

$1.3B+5.4% vs a year earlier

Sep '23Tap a barJun '26

Last 12 months: $5.2B, up 5.5% from the 12 months before. Over 5 years, sales shrank about 1.9% a year.

What the price assumes

Your guesses, our math

Move the sliders to your own view of HLF. Starting points are the company's recent numbers.

Sales growth+6% a yearRecently: +5.5% a yearProfit margin3%Last 12 months: 3.2%P/E at the end9xToday: 8.5x. Many steady companies trade at 12x to 25xShare count change+1% a yearBelow zero means buybacks; above zero means new shares (dilution)

Sales in 5 years$7.0B

Profit in 5 years$209M

Price these guesses point to$17.06+28% vs $13.30 todayAbout +5.1% a year, before dividends

What today's price needs: with a 3% margin and a 9x P/E, sales would have to grow about 0.9% a year for 5 years just to match today's price.

Simple math on your guesses, not a forecast or a price target. Real results depend on many things these sliders leave out.

Price

Price chart by TradingView.

Business quality

The checklist Warren Buffett-style investors use. Annual numbers for 2025.

3/6Mixed

MissDebt under half of equityNot relying on borrowed money.Owes more than it owns
MissNet margin 10%+Keeps at least 10 cents of profit from each dollar of sales.4.5%
PassProfitable every yearSteady profits, not one good year.10 of 10 years
PassFree cash flow positiveBrings in more cash than it spends to run and grow.$252.9M
MissShare count not growingNot diluting owners. Falling means buybacks.+4.1% in 3 years
PassGross margin 40%+Pricing power: sells for well above what it costs to make.77.9%

Revenue: $5.0B; +0.9% vs prior year
5-year growth: -1.9%/yr; revenue, per year
Total debt: $2.0B
Current ratio: 1.13x; short-term assets / bills due

From annual reports filed with the SEC. Not in this company's SEC data, so not scored: return on equity 15%+. A checklist is a starting point for research, not a verdict.

Latest quarter

Quarter ended Jun 30, 2026

Reported Aug 5

Revenue: $1.3B; +5.4% YoY
EPS: -$0.25; vs $0.48
Op. margin: 9.7%; -0.8 pts
Gross margin: 77.7%; -0.3 pts
Free cash flow: $21.6M
Share count: +1.2%; vs a year ago

Insider rating

Last 90 days

No open-market insider buys or sells in the last 90 days.

Weekly insider trend

No trades to chart yet.

Filing buzz

Last 7 days vs normal

0/ 100

This week: 0
Normal week: 0.5
vs normal: 0.0x

SEC filings of any kind. 50 means a normal week.

Institutional ownership

Steady+0.9%

Institutions added 0.9% to their holdings. 127 bought, 115 sold. 3 quarters of net buying in a row.

Shares held by institutions105.1M

Sep '24Jun '26

Safety check

From SEC filings

Share count growthYearly rate, last 3 years

+1.9%

Cash runwayAt last year's cash burn

Cash flow positive

Debt to equityLatest balance sheet: debt compared with what owners have

Owes more than it owns

Shares outstandingLatest reported

105M

Earnings reports

Last 12

Next reportIn 7 days (est.)Estimated from the same quarter last year

Results filedAug 5
Results filedMay 6
Results filedApr 14
Results filedFeb 18
Results filedNov 5, 2025

Flags and big holders

Offerings 6 months, flags 12 months, holders 90 days

5%+ holder update (passive)Aug 13 · View filing ↗Big holder 5%+ holder update (passive)Aug 6 · View filing ↗Big holder

Insider trades

Open-market buys and sells, last 90 days

No open-market buys or sells in 90 days. Grants and option exercises are left out.

"Owns after" is the insider's holding right after the trade. Pre-planned (10b5-1) sales are set up months ahead, a weaker signal.

Latest filings

Straight from SEC EDGAR

Leadership changeAug 31 · Form 8-K ↗5%+ holder update (passive)Aug 13 · Form SCHEDULE 13G/A ↗5%+ holder update (passive)Aug 6 · Form SCHEDULE 13G/A ↗Quarterly reportAug 5 · Form 10-Q ↗Earnings resultsAug 5 · Form 8-K ↗

Shares withheld for taxesFrank LambertiChief Commercial Officer

1,710 shares at $12.80 · $22K

-5% of holdings
Now owns 34,914 shares
Filed 1 day after trade

Aug 4Form 4 ↗

BoughtSophie L'heliasDirector

1,200 shares at $11.31 · $14K

+2% of holdings
Now owns 79,882 shares
Filed same day

Jun 4Form 4 ↗

3/AMay 20 · Form 3/A ↗

SoldTroy HicksChief Operating Officer

48,377 shares at $12.81 avg ($12.32 to $12.93) · $620K

-83% of holdings
Now owns 9,706 shares
Not a pre-planned sale
2 transactions
Filed 1 day after trade
Also: Option exercise, Shares withheld for taxes

May 19Form 4 ↗

Planned insider saleMay 19 · Form 144 ↗Planned insider saleMay 18 · Form 144 ↗5%+ holder update (passive)May 15 · Form SCHEDULE 13G/A ↗Planned insider saleMay 12 · Form 144 ↗3/AMay 12 · Form 3/A ↗New insiderMay 12 · Form 3 ↗

Source: SEC EDGAR filings. For informational purposes. Not investment advice.

Report a problem with this page